1 Min Read
June 9 (Reuters) - Anges Mg Inc
* Anges expects to apply in October for approval to manufacture and market treatment for severe blockage of the arteries in the legs - Nikkei Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.